Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
In a study of parenteral cancer drug pricing at 61 NCI-designated cancer centers, median price markups on 25 commonly used drugs ranged from approximately 120% to 630% over acquisition cost. The paper’s authors recommend public policy prohibiting excessive markup on parenteral chemotherapies as a means to reduce unnecessary financial burden on patients.
Oncology, Medical April 26th 2022
Healthgrades for Professionals
Is there a link between climate change and poverty? Does hate affect the risk for chronic health conditions? Is telehealth the model for medicine’s future? Or will something much more ancient be reestablished? How will the Millennial worldview affect how medicine is practiced? This archive of top physician TED talks is worth your while.
All Specialties January 19th 2022
GoodRx for Healthcare Professionals
Prescription drug prices rise each year in January and July. As we start off the new year, GoodRx Health is reporting that a total of 658 branded drugs have just had their prices increased an average of 4.9%, while 11 generic medications have seen their prices rise an average of 10.3%. That’s less than the 832 drugs that saw their price increase in January 2021. Among the biggest movers are Nucynta, paclitaxel, and Prilosec.
All Specialties January 12th 2022